Literature DB >> 18439170

Stimulation rate and the optimal interventricular interval during cardiac resynchronization therapy in patients with chronic atrial fibrillation.

Berry M van Gelder1, Albert Meijer, Frank A Bracke.   

Abstract

BACKGROUND: Optimization of cardiac resynchronization therapy (CRT) with respect to the interventricular (V-V) interval is mainly limited to pacing at a resting heart rate. We studied the effect of higher stimulation rates with univentricular and biventricular (BiV) pacing modes including the effect of the V-V interval optimization.
METHODS: In 36 patients with heart failure and chronic atrial fibrillation (AF), the effects of right ventricular (RV), left ventricular (LV), simultaneous BiV, and optimized sequential BiV (BiVopt) pacing were measured. The effect of the pacing mode and the optimal V-V interval was determined at stimulation rates of 70, 90, and 110 ppm using invasive measurement of the maximum rate of left ventricular pressure rise (LV dP/dt(max)).
RESULTS: The average LV dP/dt (max) for all pacing modalities at stimulation rates of 70, 90, and 110 ppm was 781 +/- 176, 833 +/- 197, and 884 +/- 223 mmHg/s for RV pacing; 893 +/- 178, 942 +/- 186, and 981 +/- 194 mmHg/s for LV pacing; 904 +/- 179, 973 +/- 187, and 1052 +/- 206 mmHg/s for simultaneous BiV pacing; and 941 +/- 186, 1010 +/- 198, and 1081 +/- 206 mmHg/s for BiVopt pacing, respectively. In BiVopt pacing, the corresponding optimal V-V interval decreased from 34 +/- 29, 28 +/- 28, and21 +/- 27ms at stimulation rates of 70, 90, and 110 ppm, respectively. In two individuals, LV dP/dt(max) decreased when the pacing rate was increased from 90 to 110 ppm.
CONCLUSION: In patients with AF and heart failure, LV dP/dt(max) increases for all pacing modalities at increasing stimulation rates in most, but not all, patients. The rise in LV dP/dt(max) with increasing stimulation rates is higher in biventricular (BiV and BiVopt) than in univentricular (LV and RV) pacing. The optimal V-V interval at sequential biventricular pacing decreases with increasing stimulation rates.

Entities:  

Mesh:

Year:  2008        PMID: 18439170     DOI: 10.1111/j.1540-8159.2008.01042.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  6 in total

Review 1.  Atrial Fibrillation Complicating Congestive Heart Failure: Electrophysiological Aspects And Its Deleterious Effect On Cardiac Resynchronization Therapy.

Authors:  Osmar Antonio Centurión
Journal:  J Atr Fibrillation       Date:  2009-06-01

2.  Visual LV motion and invasive LVdP/dtmax for selection and optimisation of cardiac resynchronisation therapy.

Authors:  A H M Jansen; B M van Gelder
Journal:  Neth Heart J       Date:  2008-10       Impact factor: 2.380

3.  Adverse response to cardiac resynchronisation therapy in patients with septal scar on cardiac MRI preventing a septal right ventricular lead position.

Authors:  Simon G Duckett; Matthew Ginks; Anoop Shetty; Senthil Kirubakaran; Julian Bostock; Stam Kapetanakis; Jaswinder Gill; Gerry Carr-White; Reza Razavi; C Aldo Rinaldi
Journal:  J Interv Card Electrophysiol       Date:  2011-11-30       Impact factor: 1.900

Review 4.  Atrioventricular and interventricular delay optimization in cardiac resynchronization therapy: physiological principles and overview of available methods.

Authors:  Patrick Houthuizen; Frank A L E Bracke; Berry M van Gelder
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

Review 5.  Modalities of ventricular pacing for cardiac resynchronization therapy in patients with heart failure: a meta-analysis and systematic review.

Authors:  Ailan Chen; Xinyu Chen; Yuechun Shen; Wanglin Li
Journal:  Arch Med Sci       Date:  2017-01-31       Impact factor: 3.318

6.  A multicenter prospective randomized controlled trial of cardiac resynchronization therapy guided by invasive dP/dt.

Authors:  Manav Sohal; Shoaib Hamid; Giovanni Perego; Paolo Della Bella; Shaumik Adhya; John Paisey; Tim Betts; Ravi Kamdar; Pier Lambiase; Francisco Leyva; Janet M McComb; Jonathan Behar; Thomas Jackson; Simon Claridge; Vishal Mehta; Mark Elliott; Steven Niederer; Reza Razavi; C Aldo Rinaldi
Journal:  Heart Rhythm O2       Date:  2021-01-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.